MBX Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	223.13	49.35	30.52	24.21
Short-Term Investments	168.55	212.8	50.15	18.25
Cash & Short-Term Investments	391.67	262.15	80.68	42.46
Cash Growth	41.37%	224.94%	90.00%	-
Other Receivables	1.55	0.68	0.21	0.14
Receivables	1.55	0.68	0.21	0.14
Prepaid Expenses	3.4	3.65	2.45	1.52
Other Current Assets	0.88	0.8	0.13	0.08
Total Current Assets	397.5	267.29	83.47	44.21
Property, Plant & Equipment	2.52	1.2	0.67	0.84
Other Long-Term Assets	0.05	0.05	0.05	0.04
Total Assets	400.08	268.54	84.18	45.1
Accounts Payable	3.77	5.34	1.39	0.98
Accrued Expenses	8.14	5.55	2.38	2.32
Current Portion of Leases	0.15	0.17	0.15	0.14
Total Current Liabilities	12.06	11.05	3.93	3.43
Long-Term Leases	0.47	-	0.17	0.32
Other Long-Term Liabilities	0.01	0.04	0.19	0.07
Total Liabilities	12.54	11.09	4.29	3.82
Common Stock	0.01	0.01	0	0
Additional Paid-In Capital	589.79	394.89	3.05	0.41
Retained Earnings	-202.41	-137.51	-75.58	-43.02
Comprehensive Income & Other	0.15	0.06	0.06	0
Total Common Equity	387.54	257.44	-72.47	-42.61
Shareholders' Equity	387.54	257.44	79.89	41.27
Total Liabilities & Equity	400.08	268.54	84.18	45.1
Total Debt	0.62	0.17	0.32	0.46
Net Cash (Debt)	391.05	261.98	80.35	42
Net Cash Growth	41.25%	226.04%	91.31%	-
Net Cash Per Share	11.62	24.62	78.87	62.97
Filing Date Shares Outstanding	44.9	33.42	1.26	0.67
Total Common Shares Outstanding	44.72	33.42	1.26	0.67
Working Capital	385.44	256.24	79.54	40.78
Book Value Per Share	8.67	7.70	-57.65	-63.87
Tangible Book Value	387.54	257.44	-72.47	-42.61
Tangible Book Value Per Share	8.67	7.70	-57.65	-63.87
Machinery	1.16	1.11	0.24	0.23
Construction In Progress	0.97	-	0	-
Leasehold Improvements	0.49	0.39	0.37	0.35

Source: S&P Capital IQ. Standard template. Financial Sources.